LUNG TRANSPLANTATION - ADULT (LTX) -> LTX - Immunosuppression, Therapeutics and Pharmacology Abstracts

788 - Azithromycin Prophylaxis after Lung Transplantation is Associated with Improved Survival and Graft Function

Presentation Number
788
Speakers
Session Name
POSTER SESSION 1 - POSTER SESSION: Lung Failure/Transplantation - Adult
Date
Wed, Apr 22, 2020
Time
06:00 PM - 07:15 PM
Authors

Previous ePresentation
787 - Deep Vein Thrombosis in Extracorporeal Membrane Oxygenation Bridged Lung Transplant Recipients

Next ePresentations
793 - Use of Cyclosporine Leads to Poorer Outcomes in Patients with Cystic Fibrosis Following Lung Transplant
797 - Circulating miRNAs Implication in Mechanisms of Response to ECP Therapy in BOS
807 - Insights from the UNOS Database on the Impact of Laterality on Outcomes in Lung Transplantation: Left is Not Always Right in Single Lung Transplantation
810 - Primary Graft Dysfunction Increases the Risk of Baseline Lung Allograft Dysfunction but Not Chronic Lung Allograft Dysfunction after Lung Transplantation
812 - Primary Graft Dysfunction is Associated with Increased Radiographic Atelectasis at Three Months Post-Lung Transplant
817 - Effects of a Goal Directed Transfusion Protocol on Severe Primary Graft Dysfunction after Lung Transplantation
819 - Association of Operative Day of Week with Outcomes after Lung Transplantation
822 - Echocardiographic Outcomes Following Left Ventricular Assist Device or Mitral Valve Repair in Severe Left Ventricular Dilatation with Mitral Regurgitation
825 - Racial Differences in Clinical Characteristics and Risk of Readmissions among Left Ventricular Assist Device Patients
828 - Gender Differences in Clinical Outcomes after Left Ventricular Assist Device (LVAD) Implantation - Does Device Strategy Matter?